As it pursues Mylan Pharmaceuticals for $100 million in taxes, the Internal Revenue Service is accusing the drug maker of bad faith in complying with ongoing requests to cough up documents needed for a looming trial.
In court documents filed last month, the IRS alleges that Mylan has “repeated false assurances and [offered] incomplete responses” to its efforts to obtain materials over the past two years. And the failure to produce the documents is “inexcusable,” the IRS wrote in a motion asking the US Tax Court to force the company to turn over emails, correspondence, and other paperwork (see here, here and here).
For its part, Mylan responded on Tuesday and charged — in slightly less inflammatory language — that the IRS has presented an “incomplete and inaccurate portrayal” of its willingness to cooperate. And the drug maker goes on to argue that more than 22,000 pages of “highly responsive” materials have already been given to the government.